Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abound, adware, Alfasigma, andour, Andrew, apheresed, API, ARTBio, autonomy, autoreactive, avelumab, Bavencio, BDO, BICLA, Bioscience, blister, BPCIA, breast, BridGene, British, BSc, calenderyear, carton, CBO, CCO, CFO, chance, Chen, CISO, cladribine, clearance, Cliff, CMO, column, count, creatine, credential, CSD, CSRD, CV, Da, Darmstadt, debated, decentralised, desease, Dickinson, dicontinued, disaggregated, dislose, distinguished, editor, Ellen, endeavor, epidemiological, Erlangen, erroneously, Exchangeabilitiy, FDI, feel, Fisher, forum, founder, FP, fragment, front, Frontier, GALACELA, GALARISSO, Gaza, hardware, horizon, HTA, HTAR, Hungary, Huston, IIR, ill, IMARC, IMiD, imide, immunomodulatory, incredible, Incyte, inquiring, KG, KGgA, Kite, kitting, Kymab, lentiviral, library, Lightning, linker, LivaNova, LR, magment, malignancy, malware, Mavenclad, meantime, mindset, missed, MRD, neuromodulation, novalix, Novo, nuclear, occupied, Offier, offline, OLCA, OLINGUITO, online, operationalized, outer, overseen, Oxf, Oxley, pathogenic, penetration, peptide, pervasive, PhA, phosphokinase, PHSA, PI, planet, Pls, Poland, pose, posture, predecessor, predictor, prepayment, pretreated, prorated, proteasome, QDMTT, quo, ransomware, recused, resigned, RMAT, rotate, RWE, SAPA, scanning, Schaffert, scouting, server, sharpening, showcased, Siegel, Sigmund, Simon, simplification, Singapore, sooner, SotyktuTM, stamped, Strasbourg, stuffing, Sturge, subtitle, Summer, Susanne, Sussex, synergize, TCM, teamwork, Thad, Thermo, Thompson, threat, throughput, TIS, tranche, transgene, Trustee, turnaround, Undertaxed, undiscounted, unitary, unreasonable, unrecognized, UPC, upcoming, urgent, UTPR, vector, vedoluzimab, Ventac, Vetter, Vincilaan, visit, Weizmann, Western, WG, wider, Wierda, wil, Windsor, Zaventem
Removed:
accident, accomplishing, accomplishment, acidic, Actemra, actuarial, adalimumab, ADPKD, adrenal, Advent, ago, Aleta, AMCase, AMT, ankylosing, anti, antirheumatic, Artax, Arthur, attendance, attestation, Aura, autosomal, Avila, bargaining, baricitinib, Bayer, Biochemistry, biomarker, birth, Bosley, Bradford, breakdown, Brexit, bridge, Bridging, budesonide, Cambridge, categorized, CDAI, ceiling, CF, CFTR, channel, childbearing, chimera, Chitotriosidase, chloride, cholesterol, Cimzia, CIR, circulation, cleaning, closely, clot, coding, collecting, commenced, computed, concept, concomitant, conductance, consistency, coronary, corrector, cortex, Cosentyx, credibility, creditworthy, crossing, CRP, cycle, cyst, Cystic, dataset, DDI, deceptive, Detroit, developmental, digestive, digit, discouraging, dismantling, distal, distancing, distributor, dividing, dominant, dominated, DPhil, druggable, DVT, embodying, encoded, endoscope, endoscopy, enlargement, Entyvio, EUSA, examine, excessive, exploratory, extrapolate, fat, fatigue, Fellow, Fibrocor, FIH, Fistulae, fistulizing, FITZROY, flammable, flexible, footprint, formation, futility, FVTOCI, gathered, graphic, grouped, half, heart, hedge, hope, Humira, hypothesized, ileum, immunity, immunosuppressive, impede, implicit, improve, inappropriate, induced, infliximab, injection, injured, inlicensed, innate, innovate, interface, internet, interrelated, investigate, isolated, KaNDy, Katrine, Kingston, LDL, learned, learning, Levicept, licence, Lilly, lipid, lipoprotein, LLP, London, loose, luminal, ma, macrophage, Madrid, mamalian, mandated, MANGROVE, marked, membrane, mesalamine, metabolic, mg, Michigan, mid, middle, move, moved, mucosal, Munich, naive, NeRRe, netted, Nyenrode, OA, occurring, ointment, Olumiant, outbreak, outreach, Oxford, oxygen, ozanimod, pandemic, passively, perianal, Pfizer, Pharnext, Pheno, phenotypic, Piet, poc, polycystic, polymorphic, potentiator, precisely, predominantly, pregnancy, progressing, proof, ProQR, PROTAC, quickly, ready, red, regional, regulator, remodeling, remotely, removing, renegotiation, repair, restore, restructure, returned, reversed, Rinvoq, risankizumab, Rowe, sanitation, SASU, SBCD, screened, secrete, sector, selectivity, sequelae, SIK, simplified, Skyrizi, sperm, Statin, statistically, stay, steroid, stomach, stopped, stopping, structural, subparagraph, subscribing, subset, suppressing, suspending, synthesized, Takeda, Taltz, thromboembolism, thrombotic, timeline, tofacitinib, topical, transmembrane, transparent, transplantation, triangle, triple, UCB, ulceration, unaffected, undisclosed, uniQure, unwanted, unwilling, updating, ustekinumab, vedolizumab, vein, Venture, Vermeire, viewpoint, ViiV, virtual, VTE, Wellington, wholly, Xeljanz, Zeposia
Filing tables
Filing exhibits
GLPG similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-268756, 333-260500, 333-249416, 333-231765, 333-225263, 333-218160, 333-215783, 333-211834, 333-208697, 333-204567 and 333-275886 on Form S-8 of our report dated March 23, 2023 (March 28, 2024 as to the effects of the discontinued operations described in Note 5) relating to the financial statements of Galapagos NV appearing in this Annual Report on Form 20-F for the year ended December 31, 2023.
/s/ Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises BV/SRL | |
Zaventem, Belgium | |
March 28, 2024 | |